|
|
 DNA Information - November 21, 2008
| Researchers have achieved a breakthrough in diagnosing multi drug-resistant tuberculosis (MDR-TB) by using a DNA-based test that takes just two days to yield results. The World Health Organisation (WHO) on Monday said the rapid molecular diagnostic tool will be available over the next four years in more than a dozen countries | | A Maryland pharmaceutical firm is testing a lupus drug, LymphoStat-B, to treat multiple sclerosis. The medication stops a protein found in high levels in MS lesions, which contribute to the production of cells that go against the body and instead attack healthy tissue. Human Genome Sciences has partnered with GlaxosmithKline in testing LymphoStat-B to find a cure for MS, one of four autoimmune ailments that the two firms want to find a remedy | | Pesticides were once touted as a tool of the agricultural green revolution designed to help increase crop yields but now are being blamed for causing cancer, reducing the nutritional value of some food crops and failing to boost crop yields. Researchers have found that pesticides used on crops has damaged the DNA of farmers in India, making them more susceptible to cancer | | Researchers have found that an experimental gene therapy is an effective way to help children suffering from a rare brain disease. A team of researchers from New York-Presbyterian Hospital/Weill Cornell Medicine Center have found that the gene therapy had positive effects in slowing the progression of Batten disease, or Late Infantile Neuronal Ceroid Lipofuscinosis (LINCL). LINCL is an autosomal recessive disease caused by mutations in a gene resulting in functional defects of the gene product tripeptidyl-peptidase I. This disease is usually fatal in children before the age of 13 | | Researchers have developed a new drug that can protect healthy cells from anti-cancer radiation. The drug, CBLB502, was shown to protect gastrointestinal cells and bone marrow in mice and monkeys from radiation without reducing the treatment's effectiveness. The new research could not only improve the effectiveness of radiation therapy in cancer but also help prevent radiation sickness after exposure to a nuclear accident or attack | |
|
|